266 related articles for article (PubMed ID: 2540908)
1. Phenotypic heterogeneity studied by immunohistochemistry and aneuploidy in non-small cell lung cancers.
Pujol JL; Simony J; Laurent JC; Richer G; Mary H; Bousquet J; Godard P; Michel FB
Cancer Res; 1989 May; 49(10):2797-802. PubMed ID: 2540908
[TBL] [Abstract][Full Text] [Related]
2. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
[TBL] [Abstract][Full Text] [Related]
3. In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers.
Simony J; Pujol JL; Radal M; Ursule E; Michel FB; Pujol H
Cancer Res; 1990 Jul; 50(14):4382-7. PubMed ID: 2163748
[TBL] [Abstract][Full Text] [Related]
4. Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data.
Choma D; Daurès JP; Quantin X; Pujol JL
Br J Cancer; 2001 Jul; 85(1):14-22. PubMed ID: 11437396
[TBL] [Abstract][Full Text] [Related]
5. Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer?
Ruffato A; Mattioli S; Pileri S; Daddi N; D'Ovidio F; Pilotti V; Tazzari P
Eur J Cardiothorac Surg; 2009 Mar; 35(3):463-8. PubMed ID: 19150243
[TBL] [Abstract][Full Text] [Related]
6. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal, and neuroendocrine antigens.
Broers JL; Rot MK; Oostendorp T; Huysmans A; Wagenaar SS; Wiersma-van Tilburg AJ; Vooijs GP; Ramaekers FC
Cancer Res; 1987 Jun; 47(12):3225-34. PubMed ID: 2438035
[TBL] [Abstract][Full Text] [Related]
8. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
9. NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis.
van de Velde HJ; Senden NH; Roskams TA; Broers JL; Ramaekers FC; Roebroek AJ; Van de Ven WJ
Cancer Res; 1994 Sep; 54(17):4769-76. PubMed ID: 8062278
[TBL] [Abstract][Full Text] [Related]
10. Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35.
Takahashi T; Ueda R; Song X; Nishida K; Shinzato M; Namikawa R; Ariyoshi Y; Ota K; Kato K; Nagatsu T
Cancer Res; 1986 Sep; 46(9):4770-5. PubMed ID: 3015397
[TBL] [Abstract][Full Text] [Related]
11. Antigenic phenotype and biological characteristics of two distinct sublines derived from a small cell lung carcinoma cell line.
Watanabe H; Takahashi T; Ueda R; Utsumi KR; Sato T; Ariyoshi Y; Ota K; Obata Y; Takahashi T
Cancer Res; 1988 May; 48(9):2544-9. PubMed ID: 2833350
[TBL] [Abstract][Full Text] [Related]
12. [Rudolf-Virchow Prize 1999. Genetics of respiratory tract carcinomas: correlation of genotype and phenotype].
Petersen I
Verh Dtsch Ges Pathol; 1999; 83():195-204. PubMed ID: 10714210
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of flow cytometry in non-small-cell lung cancer.
Rice TW; Bauer TW; Gephardt GN; Medendorp SV; McLain DA; Kirby TJ
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):210-7. PubMed ID: 8393505
[TBL] [Abstract][Full Text] [Related]
14. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
[TBL] [Abstract][Full Text] [Related]
15. The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung.
Jiang SX; Kameya T; Shinada J; Yoshimura H
Mod Pathol; 1999 Apr; 12(4):362-9. PubMed ID: 10229500
[TBL] [Abstract][Full Text] [Related]
16. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
17. Stratification of the biologic aggressiveness of non-small cell lung cancer using DNA flow cytometry and immunohistochemistry for the retinoblastoma protein.
Otsuka H; Funai S; Tanaka A; Hara S; Shiozaki H
Lung Cancer; 2004 Sep; 45(3):307-16. PubMed ID: 15301871
[TBL] [Abstract][Full Text] [Related]
18. Centrosome abnormalities in non-small cell lung cancer: correlations with DNA aneuploidy and expression of cell cycle regulatory proteins.
Jung CK; Jung JH; Lee KY; Kang CS; Kim M; Ko YH; Oh CS
Pathol Res Pract; 2007; 203(12):839-47. PubMed ID: 17913384
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
[TBL] [Abstract][Full Text] [Related]
20. Discrimination of human small cell and non-small cell lung tumors by a panel of monoclonal antibodies.
Tong AW; Lee JC; Stone MJ
J Natl Cancer Inst; 1986 Nov; 77(5):1023-33. PubMed ID: 3022055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
